Researchers have deciphered the function executed by a protein called b-catenin in generating blood tissue stem cells. These cells are used as a source for transplants that form part of the therapies to fight different types of leukemia. The results obtained will open the doors to produce these stem cells in the laboratory and will let patients with no compatible donors be able to benefit from this discovery in the future.